Why is Vivo Bio Tech falling/rising?

As of 04-Aug, Vivo Bio Tech Ltd. is currently priced at 33.11, reflecting an increase of 0.35 or 1.07%. Despite this positive movement today, the stock has shown a significant decline over the past week and month, with returns of -4.80% and -10.15%, respectively. The stock is trading below its moving averages across various time frames, indicating a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 69.72% against the 5-day average. While the company has a very attractive valuation with a return on capital employed (ROCE) of 8.8 and a low PEG ratio of 0.1, the decrease in promoter holding to 39.06% raises concerns about confidence in the stock.
In the broader market context, Vivo Bio Tech's recent performance contrasts sharply with the benchmark, as it has consistently underperformed against the BSE500 over the last three years, generating -13.32% returns in the past year while the benchmark has remained flat. This underperformance is compounded by weak long-term fundamentals, including a -3.36% CAGR growth in net sales over the last five years and a poor EBIT to interest ratio of 1.99, which suggests challenges in servicing debt. Overall, while the stock has seen a slight uptick today, the underlying trends and comparisons to the benchmark indicate ongoing struggles for Vivo Bio Tech in the market.